PMID: 2510618Nov 1, 1989Paper

Misoprostol versus antacid titration for preventing stress ulcers in postoperative surgical ICU patients

Annals of Surgery
M J ZinnerT D Fakouhi

Abstract

Bleeding from gastroduodenal lesions is a potentially life-threatening complication in patients subjected to overwhelming physiologic stress. Titration of gastric contents with antacid was the first prophylactic treatment regimen proved to decrease the incidence of bleeding and remains the standard by which other methods are compared. We designed a prospective double-blind, double-placebo study comparing the effectiveness of antacid titration with fixed doses of a synthetic prostaglandin E1 analog (misoprostol) for preventing stress gastritis and bleeding. To assess the success of each treatment regimen, we did endoscopic examinations before operation, 72 hours after operation, and after the patient had completed the study. A total of 281 patients entered the study (140 misoprostol, 141 antacid). The two groups were comparable with respect to preoperative parameters and type of operation. We found no statistically significant differences between the two treatment groups concerning upper gastrointestinal tract lesions or serious adverse effects. No clinically evident upper gastrointestinal hemorrhage occurred in either group. Mean gastric pH, measured at two-hour intervals during the initial 72 hours, was maintained at 4.0 or hi...Continue Reading

References

May 1, 1978·The American Journal of Digestive Diseases·E Z DajaniR E Bertermann
Feb 1, 1986·Digestive Diseases and Sciences·R L Herting, C H Nissen
Apr 1, 1987·Annals of Internal Medicine·R B ShumanG R Zuckerman
May 1, 1986·Zeitschrift für Gastroenterologie·K F Sewing
Apr 1, 1972·Annals of Surgery·R RobbinsG Essiet
Apr 1, 1971·Archives of Surgery·C E LucasA J Walt

❮ Previous
Next ❯

Citations

May 1, 1997·Journal of Magnetic Resonance Imaging : JMRI·O ErnstC L'Hermine
Oct 1, 1988·Digestive Diseases and Sciences·A M Granda
Mar 12, 2003·Current Treatment Options in Gastroenterology·Mitchell J. Spirt
Jul 13, 2011·Neurocritical Care·Clemens M SchirmerAnish Bhardwaj
May 24, 2003·Best Practice & Research. Clinical Gastroenterology·Donald R Duerksen
Aug 20, 1992·The New England Journal of Medicine·N PeledG Koren
Mar 25, 2004·Clinical Therapeutics·Mitchell J Spirt
May 19, 2009·Gastroenterology Clinics of North America·Tauseef Ali, Richard F Harty
Mar 19, 2013·Acta Anaesthesiologica Scandinavica·M KragM H Møller
Feb 10, 2012·Journal of Veterinary Emergency and Critical Care·Andrea A Monnig, Jennifer E Prittie
Jul 1, 1991·Current Problems in Surgery·T A MillerF G Moody
Aug 24, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Mohd Fahami Nur AzlinaHj Mohd Saad Qodriyah
Apr 10, 2002·Critical Care Nursing Clinics of North America·Jeanne Flannery, Denise A Tucker
Nov 2, 2005·Expert Opinion on Pharmacotherapy·Donald Castell
Jun 5, 2018·The Cochrane Database of Systematic Reviews·Ingrid ToewsJoerg J Meerpohl
Sep 1, 1994·The Annals of Pharmacotherapy·M A Smythe, B J Zarowitz
Oct 1, 1995·Postgraduate Medicine·Jack L DePriest
Jun 3, 2000·Gastroenterology Clinics of North America·U Beejay, M M Wolfe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.